Cargando…
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
The world is facing the rising emergency of SARS-CoV-2. The outbreak of COVID-19 has caused a global public health and economic crisis. Recent epidemiological studies have shown that a possible association of BCG vaccination program with decreased COVID-19-related risks, suggesting that BCG may prov...
Autores principales: | Tomita, Yusuke, Sato, Ryo, Ikeda, Tokunori, Sakagami, Takuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440160/ https://www.ncbi.nlm.nih.gov/pubmed/32863070 http://dx.doi.org/10.1016/j.vaccine.2020.08.045 |
Ejemplares similares
-
Association between HLA gene polymorphisms and mortality of COVID‐19: An in silico analysis
por: Tomita, Yusuke, et al.
Publicado: (2020) -
Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer
por: Imamura, Kosuke, et al.
Publicado: (2022) -
Statistical Concern Regarding the Relationship of Change in Mucus Plug Score with Airflow Over Time
por: Ikeda, Tokunori, et al.
Publicado: (2022) -
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
por: Sato, Ryo, et al.
Publicado: (2019) -
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
por: Tsukamoto, Hirotake, et al.
Publicado: (2022)